病例研究

New Formulation ROTAVAC 5C Has the Lowest Cold Chain Footprint Amongst Oral Rotavirus Vaccine in the World

Seamless coordination of complex pediatric Phase III clinical trial for ROTAVAC 5C® in India brings world closer to improving the global supply of affordable rotavirus vaccines.   SITUATION 乔治临床( George Clinical ) was selected by sponsor Bharat Biotech to conduct a seamless, sequential Phase III, randomized, multi-center, single-blind study to evaluate immunogenicity, safety and reactogenicity […]

了解更多
2019年11月13日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) leads China Component and Recruitment in World-First Large CPAP Device Trial

The Study Although Obstructive sleep apnea (OSA) is a very common condition that is associated with an increased risk of cardiovascular disease (CVD), there is much uncertainty over the effectiveness of treatment with nasal continuous positive airway pressure (CPAP) for the prevention of CVD. The SAVE trial was a multi-centre, open label, parallel, prospective, randomised, […]

了解更多
2017年6月20日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Scientific Leaders boost recruitment for Phase 1 Patient Study

Utilizing key therapeutic knowledge leader networks as championed by 乔治临床( George Clinical ) has again shown its effectiveness in boosting recruitment; this time for a Phase 1 renal patient trial. It is widely understood that the recruitment of patients into a Phase 1 trial can be fraught with difficulty. This difficulty arises from: A lack […]

了解更多
2017年1月23日
[addtoany buttons='facebook,twitter,linkedin']

Scientific Leadership: Our Communication Framework

Background 乔治临床( George Clinical ) provides scientific leadership to clinical trials, where peer-to-peer engagement from clinicians is leveraged to facilitate study operations. In the traditional study operations model, clinical research associates (CRAs) typically engage with site personnel, such as study coordinators, on a day-to-day basis. Principal investigators, whose expertise and seniority at the site’s operational […]

了解更多
2017年1月23日
[addtoany buttons='facebook,twitter,linkedin']

Renal Health: Recruitment Success in the Asia-Pacific

The Study 乔治临床( George Clinical ) (GC) is collaborating with a global, research-based biopharmaceutical company to evaluate the effect of a new chemical entity in subjects with type 2 diabetes and nephropathy. 乔治临床( George Clinical ) services GC is responsible for project management (PM) and monitoring throughout the Asia-Pacific. Other regions were managed by a […]

了解更多
2017年1月23日
[addtoany buttons='facebook,twitter,linkedin']

Oncology: Recruitment Success in China

The Study 乔治临床( George Clinical ) (GC) collaborated with a mid-sized global pharmaceutical company to conduct a randomized trial comparing pain relief medication for patients with moderate to severe chronic cancer pain. 乔治临床( George Clinical ) services GC was responsible for project management (PM) and monitoring across 26 sites in China. Study sites were located […]

了解更多
2017年1月23日
[addtoany buttons='facebook,twitter,linkedin']

Oncology: Multiple services; one provider

With the support of 乔治临床( George Clinical ) (GC), The George Institute (TGI) for Global Health conducted a longitudinal cohort study of approximately 9,500 hospital patients with a first time diagnosis of cancer. The study was conducted across eight countries, namely: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Thailand and Vietnam. The aim of the study […]

了解更多
2016年6月22日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Awarded Contract for Clinical Trial Management Services on Rotavirus Vaccine

乔治临床( George Clinical ) has recently been awarded the contract for full service clinical trial management services for a clinical study that seeks to improve the formulation further and also the current administration challenges for a rotavirus vaccine. The vaccine was recently launched by Indian Prime Minister Narendra Modi and developed by a Hyderabad based […]

了解更多
2016年6月21日
[addtoany buttons='facebook,twitter,linkedin']

Outstanding metrics achieved for a Phase III diabetes study in China

The World Health Organization estimates that 347 million people worldwide have diabetes, and that number is expected to continue increasing as more people move to urban cities and the population ages. Low and middle-income countries, like China and India, have been hit hardest with this disease and other NCDs. In 2010, the total number of […]

了解更多
2016年6月21日
[addtoany buttons='facebook,twitter,linkedin']

New treatment for the most serious form of stroke

Intracerebral hemorrhage is the most serious form of stroke with high rates of mortality and a low chance of recovery to functional independence. In Asia-Pacific, it affects more than one million people annually, kills one third of them and leaves most survivors with disability. For reasons yet unknown, intracerebral hemorrhage is also more prevalent in […]

了解更多
2016年6月21日
[addtoany buttons='facebook,twitter,linkedin']
George Clinical

customerservice@georgeclinical.com

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )

© 乔治临床( George Clinical ) 2023
All Rights Reserved | Privacy Policy

京ICP备2022036072号-1